Crystalline forms of an androgen receptor modulator
First Claim
1. A crystalline Form C of 4-[7-(6-cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methylbenzamide that exhibits an an X-ray powder diffraction (XRPD) pattern with characteristic peaks at 4.3±
- 0.1°
2-Theta, 6.9±
0.1°
2-Theta, 9.1±
0.1°
2-Theta, 10.6±
0.1°
2-Theta, 13.8±
0.1°
2-Theta, and 26.4±
0.1°
2-Theta.
0 Assignments
0 Petitions
Accused Products
Abstract
Described herein are amorphous and crystalline forms of the androgen receptor modulator 4-[7-(6-cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3,4]oct-5-yl]-2-fluoro-N-methylbenzamide. Also described are pharmaceutical compositions suitable for administration to a mammal that include the androgen receptor modulator, and methods of using the androgen receptor modulator, alone and in combination with other compounds, for treating diseases or conditions that are associated with androgen receptor activity.
-
Citations
21 Claims
-
1. A crystalline Form C of 4-[7-(6-cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methylbenzamide that exhibits an an X-ray powder diffraction (XRPD) pattern with characteristic peaks at 4.3±
- 0.1°
2-Theta, 6.9±
0.1°
2-Theta, 9.1±
0.1°
2-Theta, 10.6±
0.1°
2-Theta, 13.8±
0.1°
2-Theta, and 26.4±
0.1°
2-Theta. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)
- 0.1°
Specification